Research progress in targeted and immunotherapy for esophageal cancer
10.3760/cma.j.cn371439-20240805-00008
- VernacularTitle:食管癌靶向及免疫治疗研究进展
- Author:
Zhen HUANG
1
;
Fei YAN
;
Yanling MA
;
Jianhai SUN
Author Information
1. 江汉大学附属湖北省第三人民医院肿瘤科，武汉 430033
- Keywords:
Esophageal neoplasms;
Molecular targeted therapy;
Immunotherapy;
Treatment outcome
- From:
Journal of International Oncology
2025;52(1):53-59
- CountryChina
- Language:Chinese
-
Abstract:
The early diagnosis rate of esophageal cancer is low, and most of the patients are already in the middle or late stage when diagnosed, making treatment difficult, shortening the survival period and resulting in an extremely poor prognosis. In recent years, the continuous development of targeted therapy and immunotherapy has significantly improved the survival rate and therapeutic effect of esophageal cancer patients. Analyzing the research progress of targeted therapy and immunotherapy for esophageal cancer is of great significance and can provide reference for guiding the treatment of esophageal cancer.
